Announce Date | 08/07/2025 |
EPS Normalized Actual | $1.51 (Beat by $0.28) |
EPS GAAP Actual | $1.51 (Beat by $0.28) |
Revenue Actual | $0.39382B |
Revenue Surprise | Beat by $393.82M |
Announce Date | 09/30/2025 (Pre-Market) |
EPS Normalized Estimate | $1.33143 |
EPS GAAP Estimate | $1.33143 |
Revenue Estimate | $0.372742B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 1.87 | 0.57286 | 0.39382B | 19.75% | 38.54M |
FQ1 2025 (Mar 2025) | 1.85 | 0.3654 | 0.344873B | 15.71% | 1.72M |
FQ4 2024 (Dec 2024) | 0 | 0 | 0.0887B | -726.05% | 88.7M |
FQ3 2024 (Sep 2024) | 1.58 | 1.58 | 0.350954B | 15.97% | 350.95M |
FQ2 2024 (Jun 2024) | 1.22 | 1.22 | 0.316023B | 100% | 316.02M |
FQ1 2024 (Mar 2024) | 1.35 | 1.35 | 0.290706B | 100% | 290.71M |
FQ4 2023 (Dec 2023) | -4.45 | -4.45 | 0.732709B | 100% | 732.71M |
FQ3 2023 (Sep 2023) | 1.3 | 1.3 | 0.294907B | 100% | 294.91M |
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
1.33143
Consensus Revenue Estimates
0.372742B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 2.62 | -- | 2.62 | 2.62 | 1 |
FQ3 2027 (Sep 2027) | 1.65 | -- | 1.65 | 1.65 | 1 |
FQ2 2027 (Jun 2027) | 2.58 | -- | 2.58 | 2.58 | 1 |
FQ1 2027 (Mar 2027) | 2.23 | -- | 2.23 | 2.23 | 1 |
FQ4 2026 (Dec 2026) | 2.20167 | -- | 2.20167 | 2.20167 | 1 |
FQ3 2026 (Sep 2026) | 1.90333 | -- | 1.90333 | 1.90333 | 1 |
FQ2 2026 (Jun 2026) | 1.58667 | -17.86 | 1.58667 | 1.58667 | 1 |
FQ1 2026 (Mar 2026) | 1.695 | -9.14 | 1.695 | 1.695 | 1 |
FQ4 2025 (Dec 2025) | 1.65333 | -- | 1.65333 | 1.65333 | 1 |
FQ3 2025 (Sep 2025) | 1.33143 | -18.67 | 1.33143 | 1.33143 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.58B | -- | 0.58B | 0.58B | 1 |
FQ3 2027 (Sep 2027) | 0.55B | -- | 0.55B | 0.55B | 1 |
FQ2 2027 (Jun 2027) | 0.52B | -- | 0.52B | 0.52B | 1 |
FQ1 2027 (Mar 2027) | 0.45B | -- | 0.45B | 0.45B | 1 |
FQ4 2026 (Dec 2026) | 0.47B | -- | 0.47B | 0.47B | 1 |
FQ3 2026 (Sep 2026) | 0.43B | -- | 0.43B | 0.43B | 1 |
FQ2 2026 (Jun 2026) | 0.41B | 2.9 | 0.41B | 0.41B | 1 |
FQ1 2026 (Mar 2026) | 0.41B | 16.36 | 0.41B | 0.41B | 1 |
FQ4 2025 (Dec 2025) | 0.41B | 78.55 | 0.41B | 0.41B | 1 |
FQ3 2025 (Sep 2025) | 0.37B | 5.85 | 0.37B | 0.37B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
1
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 1.29714 | 1.87 | 0.57286 | 30.63% |
FQ1 2025 (Mar 2025) | 1.4846 | 1.85 | 0.3654 | 19.75% |
FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
FQ3 2024 (Sep 2024) | 1.58 | 1.58 | 100% | |
FQ2 2024 (Jun 2024) | 1.22 | 1.22 | 100% | |
FQ1 2024 (Mar 2024) | 1.35 | 1.35 | 100% | |
FQ4 2023 (Dec 2023) | -4.45 | -4.45 | 100% | |
FQ3 2023 (Sep 2023) | 1.3 | 1.3 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $0.36B | $0.39B | $38.54M | 9.78% |
FQ1 2025 (Mar 2025) | $0.34B | $0.34B | $1.72M | 0.5% |
FQ4 2024 (Dec 2024) | $0B | $0.09B | $88.7M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.35B | $350.95M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.32B | $316.02M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.29B | $290.71M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.73B | $732.71M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.29B | $294.91M | 100% |